Faslodex (fulvestrant), a new drug for metastatic breast cancer

      You'll start hearing about Faslodex (fulvestrant), a new drug for metastatic breast cancer.

      It's for postmenopausal women whose cancer progresses on tamoxifen or another antiestrogen.

      In these women, Faslodex delays tumor progression at least as well as the aromatase inhibitor Arimidex (anastrozole).

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote